<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-050774</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">8-Hydroxy-2'-deoxyguanosine and lipid peroxidation in patients with heart failure</dc:title>
<dc:description xml:lang="en">Introduction and objectives. Heart failure is associated with increased free radical production, which leads to a state of oxidative stress. Known markers of oxidative stress include 8-hydroxy-2'-deoxyguanosine, which reflects oxidative damage to DNA, and lipid peroxidation, which can be used to quantify damage to lipid-rich structures. The aims of this study were to compare 8-hydroxy-2'-deoxyguanosine and lipid peroxidation levels in heart failure patients and healthy subjects and to assess how these levels are influenced by heart failure etiology. Methods. The study included 78 patients (57 male, age 64 [14] years) with heart failure and 12 control subjects. Patients completed a questionnaire and were graded according to the New York Heart Association classification. Doppler echocardiography was performed and blood samples were obtained. 8-hydroxy-2'-deoxyguanosine and lipid peroxidation levels were determined. Results. Significant differences were observed between patients and control subjects in 8-hydroxy-2'-deoxyguanosine and lipid peroxidation levels, at 0.34 (0.54) ng/mL vs 0.04 (0.07) ng/mL (P&lt;.05), and 18 (10) &amp;#956;M vs 8 (3) &amp;#956;M (P&lt;.01), respectively. Subsequent analysis showed that heart failure etiology had a significant effect on the levels of the two markers (P&lt;.05), which were highest in patients with hypertensive cardiomyopathy. Conclusions. Levels of 8-hydroxy-2'-deoxyguanosine and lipid peroxidation were higher in heart failure patients than in control subjects. The most significant increases were found in patients with hypertensive cardiomyopathy</dc:description>
<dc:creator>Jordán, Alejandro</dc:creator>
<dc:creator>Portolés, Manuel</dc:creator>
<dc:creator>Cortés, Raquel</dc:creator>
<dc:creator>Rivera, Miguel</dc:creator>
<dc:creator>Pérez-Boscá,  José L</dc:creator>
<dc:creator>Roselló-Lletí, Esther</dc:creator>
<dc:creator>Payá, Rafael</dc:creator>
<dc:creator>Salvador, Antonio</dc:creator>
<dc:creator>García de Burgos, Fernando</dc:creator>
<dc:creator>Valero, Ricardo</dc:creator>
<dc:creator>Marín, Francisco</dc:creator>
<dc:creator>Sogorb, Francisco</dc:creator>
<dc:creator>Bertomeu, Vicente</dc:creator>
<dc:creator>Miró, Vicente</dc:creator>
<dc:creator>Martínez-Dolz, Luís</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. La insuficiencia cardiaca está asociada con un incremento en la producción de radicales libres, llegándose al estado de estrés oxidativo. Se conocen diversos marcadores de estrés oxidativo, como la 8-hidroxi-2'-desoxiguanosina, marcador del daño oxidativo en el ADN, y la peroxidación lipídica que permite cuantificar el daño en las estructuras ricas en lípidos. El propósito de este estudio es comparar los valores de 8-hidroxi-2'-desoxiguanosina y de peroxidación lipídica en pacientes con insuficiencia cardiaca y sujetos sanos, y evaluar la influencia de la etiología. Métodos. Estudiamos a 78 pacientes (57 varones, edad 64 ± 14 años) diagnosticados de insuficiencia cardiaca y a 12 controles. Los pacientes completaron un cuestionario y fueron clasificados de acuerdo con la New York Heart Association. Se les realizó un estudio eco-Doppler y extracción de sangre. Medimos las concentraciones de 8-hidroxi-2'-desoxiguanosina y de peroxidación lipídica. Resultados. Al comparar los valores de 8-hidroxi-2'-desoxiguanosina y peroxidación lipídica entre pacientes y controles obtuvimos diferencias significativas (0,34 ± 0,54 frente a 0,04 ± 0,07 ng/ml, p &lt; 0,05 y 18 ± 10 frente a 8 ± 3 &amp;#956;mol/l, p &lt; 0,01, respectivamente). Cuando comparamos las concentraciones de los 2 marcadores según la etiología de la insuficiencia cardiaca encontramos diferencias significativas en ambos (p &lt; 0,05), que fueron mayores en la miocardiopatía hipertensiva. Conclusiones. Los valores de 8-hidroxi-2'-desoxiguanosina y peroxidación lipídica se encuentran aumentados en los pacientes con insuficiencia cardiaca al compararlos con los controles. El incremento más importante lo encontramos en pacientes con miocardiopatía hipertensiva</dc:description>
<dc:source>Rev Esp Cardiol;59(11): 1140-1145, nov. 2006. tab, graf</dc:source>
<dc:identifier>ibc-050774</dc:identifier>
<dc:title xml:lang="es">Valores de 8-hidroxi-2'-desoxiguanosina y de peroxidación lipídica en pacientes con insuficiencia cardiaca</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d5744^s22002</dc:subject>
<dc:subject>^d3867^s22002</dc:subject>
<dc:subject>^d23743^s22031</dc:subject>
<dc:subject>^d32101^s22031</dc:subject>
<dc:subject>^d6486^s22032</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:type>article</dc:type>
<dc:date>200611</dc:date>
</metadata>
</record>
</ibecs-document>
